Atlas Salt Announces Filing of NI 43-101 Technical Report for the Updated Feasibility Study of Its Great Atlantic Salt Project

ST. GEORGE'S, NEWFOUNDLAND AND LABRADOR / ACCESS Newswire / November 6, 2025 /Atlas Salt Inc. ("Atlas Salt" or the "Company") (TSXV:SALT)(OTCQB:REMRF)(FRA:9D00) announces that the Company has filed on ...

Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share 11 new research studies highlighting advancements in oncology and ...

SimplyTest Partners with Evexia Diagnostics to Expand Access to PERIO and 4-Point Cortisol Tests for Functional and Integrative Health Practitioners

SimplyTest (R) is proud to announce a new partnership with Evexia Diagnostics, a premier provider of diagnostic laboratory services for functional and integrative medicine. Through this collaboration, ...
The Globe and Mail

Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

Third quarter 2025 revenue of $205.7 million decreased by 4% year-over-year but was flat when excluding previously discussed headwinds 1 of $8.1 million, consistent with management expectations. Third ...